{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:43:23Z","timestamp":1791247403083,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.tiv.2009.03.008","type":"journal-article","created":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T09:22:32Z","timestamp":1238145752000},"page":"748-753","source":"Crossref","is-referenced-by-count":100,"title":["Functional expression, inhibition and induction of CYP enzymes in HepaRG cells"],"prefix":"10.1016","volume":"23","author":[{"given":"Miia","family":"Turpeinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Tolonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2009.03.008_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","article-title":"The conduct of in vitro and in vivo drug\u2013drug interaction studies: a PhRMA perspective","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.21536","article-title":"Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor","volume":"45","author":"Cerec","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2009.03.008_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/026119290603400113","article-title":"Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54","volume":"34","author":"Coecke","year":"2006","journal-title":"Alternatives to laboratory animals: ATLA"},{"key":"10.1016\/j.tiv.2009.03.008_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1081\/DMR-100100574","article-title":"A commentary on the use of hepatocytes in drug metabolism studies during drug discovery and development","volume":"32","author":"Cross","year":"2000","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.tiv.2009.03.008_bib6","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.tiv.2009.03.008_bib7","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200043335414","article-title":"Human hepatocytes in primary culture: the choice to investigate drug metabolism in man","volume":"5","author":"Gomez-Lechon","year":"2004","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.tiv.2009.03.008_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0309-1651(82)90187-4","article-title":"High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver","volume":"6","author":"Guguen-Guillouzo","year":"1982","journal-title":"Cell Biology International Reports"},{"key":"10.1016\/j.tiv.2009.03.008_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0300-483X(93)90065-Z","article-title":"Use of human hepatocyte cultures for drug metabolism studies","volume":"82","author":"Guillouzo","year":"1993","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2009.03.008_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/17425255.4.10.1279","article-title":"Evolving concepts in liver tissue modeling and implications for in vitro toxicology","volume":"4","author":"Guillouzo","year":"2008","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/j.tiv.2009.03.008_bib11","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2174\/1568026043387188","article-title":"Cytochromes P450 in the bioactivation of chemicals","volume":"4","author":"Ioannides","year":"2004","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.tiv.2009.03.008_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/dmd.107.019901","article-title":"Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies","volume":"36","author":"Josse","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0928-0987(01)00135-X","article-title":"Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation","volume":"13","author":"LeCluyse","year":"2001","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tiv.2009.03.008_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib17","first-page":"435","article-title":"Engineering human hepatoma cells with key transcription factors to generate metabolically competent hepatic models","volume":"23","author":"Martinez-Jimenez","year":"2006","journal-title":"ALTEX: Alternativen zu Tierexperimenten"},{"key":"10.1016\/j.tiv.2009.03.008_bib18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Archives of Toxicology"},{"key":"10.1016\/j.tiv.2009.03.008_bib19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jms.1239","article-title":"In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC\/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies","volume":"42","author":"Tolonen","year":"2007","journal-title":"Journal of Mass Spectrometry"},{"key":"10.1016\/j.tiv.2009.03.008_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejps.2004.10.006","article-title":"Multiple 450 substrates in single run: rapid and comprehensive in vitro interaction assay","volume":"24","author":"Turpeinen","year":"2005","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tiv.2009.03.008_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejps.2006.06.005","article-title":"Cytochrome P450 (CYP) inhibition screening: comparison of three tests","volume":"29","author":"Turpeinen","year":"2006","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.tiv.2009.03.008_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/138920006778520633","article-title":"The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico","volume":"7","author":"Turpeinen","year":"2006","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.tiv.2009.03.008_bib23","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/00498250701658312","article-title":"Predictive value of animal models for human cytochrome P450 (CYP)-mediated metabolism: a comparative study in vitro","volume":"37","author":"Turpeinen","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tiv.2009.03.008_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.104.002766","article-title":"Selective inhibition of human cytochrome P4502C8 by montelukast","volume":"33","author":"Walsky","year":"2005","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.tiv.2009.03.008_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","article-title":"Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation","volume":"392","author":"Zanger","year":"2008","journal-title":"Analytical and Bioanalytical Chemistry"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723330900071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723330900071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T04:17:34Z","timestamp":1558239454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723330900071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S088723330900071X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2009.03.008","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}